Treating Radioactive Iodine-Refractory Differentiated Thyroid Cancer (RAI-R-DTC) with Lenvatinib - Episode 1

Real-World Outcomes Data on Lenvatinib as Monotherapy in Patients with RAI-R-DTC

Dr Lori Wirth reviews real-world outcomes data on lenvatinib treatment in patients with RAI-R-DTC and how they compare to the SELECT trial.